Citeline Podcasts
1,366 episodes - English - Latest episode: 2 days ago - ★★★★★ - 24 ratingsCiteline places biopharma and medical device professionals, and those who focus on these industries, at the forefront of knowledge and insight, by providing the perfect combination of news and information together with penetrating insight and analysis. Citeline is a leader in the field of healthcare industry information.
Homepage Apple Podcasts Google Podcasts Overcast Castro Pocket Casts RSS feed
Episodes
EPR Consultant Urges Producers To Start Collecting Packaging Data
July 12, 2024 15:59 - 16 minutes - 10.4 MBIn this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.
Improving Communication: The Relationship Between Biotech And Biopharma
July 10, 2024 13:41 - 20 minutes - 16.4 MBImproving Communication: The Relationship Between Biotech And Biopharma by Citeline
【3分で解説 世界のファーマ】第19回 FDA「密な面談」を企業に呼び掛け (Japanese-language podcast)
July 09, 2024 04:49 - 3 minutes - 4.32 MB世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 今回取り上げた記事はこちら 「US FDA’s Cell-Gene Therapy Office Head Wants Sponsors To Seek Out Meetings（ 邦題意訳：米国FDAの細胞遺伝子治療室長「もっと面談を」企業に求める理由は）」 （日本語版） [Japanese version’s URL to be published] ※全文の閲覧には情報の登録（無料）が必要です。 （英語版） https://pink.citeline.com/PS154749/US-FDAs-Cell-Gene-Therapy-Office-Head-Wants-Sponsors-To-Seek-Out-Meetings ※全文の閲覧には購読（有料）が必要です。 世界の製薬ビジネスメディアScrip（スクリップ）とは？ https://www.citeline....
Scrip's Five Must-Know Things - 8 July 2024
July 08, 2024 02:52 - 15 minutes - 25.8 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 5 July 2024. In this episode: US approval for Lilly’s Alzheimer's contender; the challenges and rewards of late-stage ADCs; Eisai regains control of ADC from BMS; RSV vaccine developers hit by declining expectations; and an interview with Amgen’s Ian Thompson. https://scrip.citeline.com/SC150550/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-kno...
Scrip M&A Podcast: A Midyear Review of Biopharma Dealmaking and Expectations of What's Ahead
July 05, 2024 19:15 - 48 minutes - 28.9 MBScrip's Joseph Haas, Mandy Jackson and Kevin Grogan discuss the biopharma dealmaking environment as we reach the midpoint of 2024. Haas reviews dealmaking data from the first six months of the year and discusses what experts expect in the months ahead. Jackson and Grogan talk about the industry mood coming out of the annual BIO conference in June and what they heard at the meeting.
Non-Invasive Solutions: Exploring The Role Of Breath Biopsies In Early Detection
July 05, 2024 10:48 - 25 minutes - 16.9 MBIn this episode of the In Vivo podcast, Billy Boyle, CEO of Owlstone Medical, discusses how his company is developing several breath biopsy products for use by clinicians, biopharma companies and researchers.
In Vivo Podcast Episode with Stefan Woxström
July 02, 2024 11:27 - 27 minutes - 17.3 MBIn Vivo Podcast Episode with Stefan Woxström by Citeline
How To Innovate For The Ages, With Bayer’s Reese Fitzpatrick And Rachel Koontz
July 01, 2024 07:13 - 47 minutes - 110 MBAspirin is celebrating its 125th anniversary this year. To find out what brand owner Bayer Consumer Health is doing to celebrate this occasion, and what it is doing to take the brand into the next 125 years, HBW Insight chats with the company’s senior vice president, Global Head Allergy, Cough/Cold, Pain and Heart Health, Reese Fitzpatrick, and head of R&D, North America and Therapeutics, Rachel Koontz. Already used for a variety conditions by consumers and patients across the world, the Aspi...
Scrip's Five Must-Know Things - 1 July 2024
July 01, 2024 03:08 - 16 minutes - 27.1 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 28 June 2024. In this episode: global CEO remuneration; another late-stage loss for Merck KgaA; deals shift to smaller M&A, partnering; Bayer’s Parkinson’s bets bear fruit; and India looks to innovate CAR-T models. https://scrip.citeline.com/SC150517/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Over the Counter: EPR Consultant Urges Producers To Start Collecting Packaging Data
June 29, 2024 17:57 - 16 minutes - 10.4 MBIn this episode, HBW chats with Michael Washburn, principal at Washburn Consulting, on how producers of single-use packaging subject to extended producer responsibility laws rolling out in Oregon, Colorado and California next year can tackle the tedious work of collecting data on packaging materials.
Drug Fix: What’s In And Out Of US FDA’s Diversity Action Plan Guidance, AI Guidance Also Coming
June 28, 2024 19:15 - 35 minutes - 22.8 MBPink Sheet reporter and editors discuss what the FDA included in its long-awaited guidance on clinical trial diversity action plans, along with what was left out (:35), as well as an upcoming guidance on the use of artificial intelligence in regulatory decision-making (27:30). More On These Topics From The Pink Sheet Diversity Action Plans Should Be Brief And Waiver Requests Filed Early, US FDA Says: https://pink.citeline.com/PS154894/Diversity-Action-Plans-Should-Be-Brief-And-Waiver-Reques...
China Biotech Podcast - 26 June 2024 (Chinese language)
June 26, 2024 05:01 - 26 minutes - 22 MBGuest speaker “Angus” Shipo Xie of Hankun Law joins Brian Yang to discuss new overseas data transfer rules, while Dexter Yan explains China biotechs' Hutchmed, Jiangsu Hengrui and Innovbent Bio’s clinical data readouts at the recent EHA and ADA annual meetings. https://scrip.citeline.com/SC150487/China-Biotech-Podcast-EHAADA Playlist: https://soundcloud.com/citelinesounds/sets/chinese-language-biopharma
Scrip's Five Must-Know Things - 24 June 2024
June 24, 2024 03:30 - 16 minutes - 26.5 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 21 June 2024. In this episode: the outlook for 2025 launches; Merck confident in new pneumococcal vaccine; multiple US setbacks for Japanese firms; Stock Watch on Moderna missteps; and Sun’s North America head talks plans and strategy. https://scrip.citeline.com/SC150476/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Lung Life AI's CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB
June 21, 2024 12:00 - 26 minutes - 48.5 MBIn this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI’s journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement and compliance with the US FDA Lab D...
Lung Life AI CEO Shares Regulatory And Reimbursement Journey For Lung Cancer Diagnostic, Lung LB
June 21, 2024 12:00 - 26 minutes - 48.5 MBIn this episode, Medtech Insight reporter Natasha Barrow speaks to LungLife AI CEO Paul Pagano. Lung Life AI is a US-based AIM-listed medical technology company that has developed a liquid biopsy test for the early detection of lung cancer called Lung LB. Pagano runs through the highlights of Lung Life AI’s journey to date and its future ambition for a strategic partnership. He also provides advice to similar diagnostic companies seeking reimbursement and compliance with the US FDA Lab D...
The Power Of Herbs For Women’s Wellness, With The SABI’s Hilary Metcalfe and Anna Cave-Bigley
June 17, 2024 08:15 - 35 minutes - 80.9 MBIn this episode, HBW Insight chats with women’s health start-up The SABI about the power of herbal medicine for hormonal wellness. “Inspired by a series of painfully honest conversations they had about their hormonal and emotional challenges,” The SABI markets a range of herbal infusions aimed at alleviating some of the impacts of painful periods and hormonal imbalances, such as digestive discomfort, sleep disruption and anxiety. The SABI founders Hilary Metcalfe and Anna Cave-Bigley also rev...
Scrip's Five Must-Know Things - 17 June 2024
June 17, 2024 02:45 - 15 minutes - 25.2 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 14 June 2024. In this episode: Boehringer best in MASH?; biopharma funding on an upswing?; Moderna’s combo jab; clinical trial recover from pandemic; and Astellas’s US commercial head speaks. https://scrip.citeline.com/SC150442/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Building And Scaling Your Workforce: The Importance Of A Flexible Delivery Model In 2024 & Beyond
June 14, 2024 21:12 - 22 minutes - 13.8 MBIn this podcast, Janelle Hart, Managing Editor, Citeline, joins industry experts Jessica Wall, Director of Talent Acquisition, and Morgan Seaman, Associate Director of FSS Operations, both from Advanced Clinical, to discuss the latest trends and challenges in building, scaling and differentiating workforces in the life sciences sector. Talent acquisition is central to fostering creativity and innovation within any organization. In today’s highly competitive and fast-moving life sciences sect...
June 2024 Datamonitor Healthcare Podcast: ASCO 2024
June 14, 2024 13:52 - 43 minutes - 26.8 MBThe oncology team from Datamonitor Healthcare and healthcare journalist, Alaric, provide broad analytical coverage of key highlights from the ASCO 2024 conference. Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836 Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz TuneIn - https://tunein.com/podcasts/Business--Economics-Podcasts/Pharma-Intellige...
China Biotech Podcast - 14 June 2024 (Bilingual Chinese/English)
June 14, 2024 05:30 - 27 minutes - 18.3 MBGuest speaker, US-based Pink Sheet senior writer Sarah Karlin-Smith, joins Brian Yang and Dexter Yan in China to discuss the recent BIO Conference, updates to the planned US BIOSECURE Act and industry preparations for its impact. Dexter also discusses China biotech's data highlights from ASCO 2024. https://scrip.citeline.com/SC150438/China-Biotech-Podcast-BIOSECURE-Act-Updates--ASCO-Highlights Playlist: https://soundcloud.com/citelinesounds/sets/chinese-language-biopharma
ASCO 결산: 암 연구의 미래는? (Korean-language podcast)
June 13, 2024 00:52 - 3 minutes - 8.33 MB글로벌 제약업계는 암 연구의 미래를 어떻게 보고 있을까? Scrip의 ASCO 현장 취재 기사를 요약한 내용입니다. https://scrip.citeline.com/SC150378/ASCO-Roundup-Looking-For-The-Future-Of-Cancer-Research Playlist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
Scrip's Five Must-Know Things - 10 June 2024
June 10, 2024 02:49 - 15 minutes - 25.1 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 7 June 2024. In this episode: BIO Notebook; ASCO roundup; data on Carvykti in community at ASCO; strong new results for tirzepatide in MASH; and orphan slowdown signals new path ahead. https://scrip.citeline.com/SC150401/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
The Generics Bulletin Podcast: Teva, Sandoz, Sawai and US Orange Book patents
June 07, 2024 14:02 - 24 minutes - 22 MBGenerics Bulletin's editorial team discusses the latest strategic developments for major industry players Teva, Sandoz and Sawai, as well as explaining the recent debate over US patent listings in the FDA's Orange Book.
China Biotech Podcast - 5 June 2024 (Chinese language)
June 05, 2024 00:44 - 23 minutes - 17.5 MBGuest speaker Guangzuo Luo, chief scientific officer of Bioncetech, joins China-based editors Brian Yang and Dexter Yan in this episode, which looks at Chinese biotechs going global, and the opportunities and challenges in the latest industry latest trends. https://scrip.citeline.com/SC150370/China-Biotech-Podcast-Going-Global-Trends-Rare-Disease-Drug-Development Playlist: https://soundcloud.com/citelinesounds/sets/chinese-language-biopharma?si=80b1209c44874afa9c44bf7d30538320&utm_source=cli...
JB CEO On CDMO Growth, Red Sea Crisis And More
June 04, 2024 00:52 - 34 minutes - 23.2 MBIn an interview with Scrip, JB CEO Nikhil Chopra addresses rumours of a sale of a stake in the Indian pharma/CDMO company by private equity fund KKR, recent acquisitions, including from Novartis, as well as JB's ambitions to ramp up the cardiology segment and its CDMO business, which already has major clients including J&J. https://scrip.citeline.com/SC150350/Amid-Talk-Of-KKR-Stake-Sale-JB-CEO-Stresses-Business-As-Usual
Scrip's Five Must-Know Things - 3 June 2024
June 03, 2024 05:04 - 15 minutes - 24.4 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 31 May 2024. In this episode: ASCO preview; Asahi’s US acquisition; Novartis aims for renal disease dominance; paying for gene therapies; and US BIOSECURE Act diluted. https://scrip.citeline.com/SC150361/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
The Scrip Awards Podcast. Episode 1: Genmab: The Ongoing Evolution Of Europe’s Antibody Powerhouse
May 31, 2024 15:37 - 22 minutes - 14.4 MBAn interview with Genmab’s Jan van de Winkel to mark 25 years of the company, and 20 years of the Scrip Awards. A brief history of the antibody-focused biotech company so far, and its plans for future expansion.
How Corporate Sustainability Reporting ‘Just Got Serious,’ With CEN-ESG’s Jasper Crone
May 31, 2024 15:13 - 50 minutes - 115 MBIn this episode we unpack the Corporate Sustainability Reporting Directive (CSRD) with the help of ESG expert Jasper Crone, drilling down into exactly what consumer healthcare companies need to know about this enormously complex and significant piece of EU legislation. 3:30 Introduction to the CSRD 7:45 What companies are affected by the CSRD 15:00 Specific implications for consumer health companies 21:00 Getting materiality right 25:00 CSRD to do list 32:00 Who’s afraid of targets? 37:00 Wh...
Navigating IND Applications & Pre-IND Meetings: Key Considerations And Misconceptions
May 31, 2024 06:38 - 37 minutes - 22 MBAdvancing Investigational New Drugs (INDs) can be a complex process, especially for smaller companies. Listen to your free podcast now as Marcus Delatte, PhD, Vice President at Allucent and Harshini Neelakantan, Executive Director at Ridgeline Therapeutics discuss best practices and considerations for leveraging your pre-IND meeting and submitting a successful IND application. Listen now for insights into: • Current trends and challenges related to IND submissions • The purpose and benefits...
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovation
May 29, 2024 13:56 - 35 minutes - 25.6 MBAstellas Pharma’s chief commercial officer, Claus Zieler, discusses the biopharma industry’s responsibility to drive change in health care.
'CorpPharma Is Not Just A Cost Component’ – Showcasing Value As Well As Innovationorate Crossbreeze
May 29, 2024 13:56 - 35 minutes - 25.6 MBAstellas Pharma’s chief commercial officer discusses the biopharma industry’s responsibility to drive change in health care.
China Biotech CEO Interview - NeuShen's Joan Huaqiong Shen
May 28, 2024 07:32 - 45 minutes - 26.5 MBNeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She also discusses two leading assets for schizophrenia and epilepsy in first-in-human studies, as well as a gene therapy collaboration for ALS with UMass's Gao Lab. https://scrip.citeline.com/SC150328/China-Biotech-CEO-Interview-Starting-A-CNS-Venture-In-An-Economic-Downturn Playlist: https://on.soundcloud.com/AaFyPUxfD2RiDEis5
China Biotech CEO Interview - NeuShen's Joan Huaqioing Shen
May 28, 2024 07:32 - 45 minutes - 26.5 MBNeuShen CEO Joan Shen discusses with Brian Yang about developing CNS drugs in China, the venture's business rationale, challenges and fundraising. She also discusses two leading assets for schizophrenia and epilepsy in first-in-human studies, as well as a gene therapy collaboration for ALS with UMass's Gao Lab.
Citeline Japan Awards 2024 - Enter Now! (Bilingual English/Japanese)
May 28, 2024 02:45 - 5 minutes - 12.1 MBAs the 15 July entry deadline for the 3rd edition of the annual Citeline Japan Awards approaches, join us in this bilingual English/Japanese podcast to learn more about the categories and event itself. (Japanese starts at 2' 25".) English event site: https://www.citeline.com/en/awards/citelinejapanawards Japanese event site: https://www.citeline.com/ja-jp/awards/citelinejapanawards
Scrip's Five Must-Know Things - 27 May 2024
May 27, 2024 06:31 - 16 minutes - 25.9 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 24 May 2024. In this episode: Biogen’s immunology acquisition; AstraZeneca looks to cement respiratory lead; why US FTC is tough on pharma; the US election’s impact on pharma; and how new AI tools are impacting medical affairs. https://scrip.citeline.com/SC150324/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Drug Fix: Novel Clinical Trial Reg Problems, NIH Drug ‘Access Plans’, Good Ole Days Of Woodcock
May 24, 2024 16:08 - 23 minutes - 14.9 MBPink Sheet editors discuss the US FDA’s consideration of regulatory changes to promote innovative clinical trial designs (:32), an NIH proposal to require patent licensees create plans to ensure access to the commercialized product (7:29), and lawmakers longing for the days when Janet Woodcock ran the FDA’s Center for Drug Evaluation and Research (15:35). More On These Topics From The Pink Sheet ‘Antiquated’ Regulations Slowing Adoption of Innovative Clinical Trial Approaches: https://pink....
【3分で解説 世界のファーマ】第18回 GLP-1を超える肥満治療薬のカギとは？(Japanese-language podcast)
May 23, 2024 00:08 - 3 minutes - 8.07 MB世界の製薬ビジネスを伝える「Scrip」と、各国で変化する製薬関連の規制に特化した「Pink Sheet」。普段は英語で発信する2つのオンラインメディアから、今注目の話題を日本語で短くまとめてお届けします。 今回取り上げた記事はこちら 「Hibernating Squirrels And Exercise In A Pill: The Next Wave of Cardiometabolic Therapies（ 邦題意訳：GLP-1を超える心代謝系治療薬のヒントは、冬眠するリスか、地道な運動か）」 （日本語版） https://www.citeline.com/ja-jp/resources/hibernating-squirrels-and-exercise-in-a-pill ※全文の閲覧には情報の登録（無料）が必要です。 （英語版） https://scrip.citeline.com/SC150222/Hibernating-Squirrels-And-Exercise-In-A-Pill-The-Next-Wave-of-Cardiometabolic-Ther...
Closed Loop Medicine: Pairing Software With Drugs To Optimize Dosing
May 22, 2024 14:31 - 25 minutes - 13 MBIn this episode of the In Vivo podcast, Hakim Yadi, CEO and co-founder of UK techbio company Closed Loop Medicine, discusses how his company is pairing software and predictive analytics with medications old and new to tailor drug dosing to each patient.
Leading PRO Discusses Plans For Administering State EPR Programs
May 21, 2024 20:41 - 36 minutes - 25.5 MBIn this episode, HBW chats with John Hite of the leading producer responsibility organization administering three Extended Producer Responsibility laws launching next year. With a 1 July deadline to register for his PRO, Circular Action Alliance, Hite discusses steps companies should take now, how his organization will assist producers and expectations on fee collection.
개발 VS 딜메이킹: 블록버스터 신약을 확보하는 방법 (Korean-language podcast)
May 21, 2024 01:21 - 3 minutes - 7.79 MB빅파마 기업들의 블록버스터 신약 확보 전략에 대한 Scrip 기사를 요약한 내용입니다. https://scrip.citeline.com/SC150256/Development-Versus-Dealmaking-How-To-Obtain-A-Blockbuster Playlist: https://soundcloud.com/citelinesounds/sets/korean-language-biopharma-mini
How To Grow A Consumer Health Brand, With TheOTCLab’s Albert Swane
May 20, 2024 14:28 - 32 minutes - 73.5 MBIn this episode, HBW Insight catches up with Albert Swane, founder and CEO of Dutch consumer healthcare firm, TheOTCLab, to talk about business strategy. Having grown the company with widely successful European OTC medical devices like Dr. Yglo, FungeX and Kidsner, Swane is perfectly placed to explain how to create and grow OTC brands. Swane also offers some sage advice on partnering, reflects on the fantastic opportunity of TheOTCLabs expanding into the US, and shares his experiences of usin...
Scrip's Five Must-Know Things - 20 May 2024
May 20, 2024 03:48 - 16 minutes - 27.5 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 17 May 2024. In this episode: the life of a blockbuster; blockbusters by indication; gene therapy struggles; sun shines on AstraZeneca and GSK; and Korean ventures look to Japan. https://scrip.citeline.com/SC150281/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Drug Fix: BIOSECURE Act Advances, Trial Diversity Sticks, Platform Principles Without Designation
May 17, 2024 18:08 - 38 minutes - 24.5 MBPink Sheet editors and reporter consider the implications of the BIOSECURE Act as it advances through a House committee (:30), whether industry would improve clinical trial diversity with tougher enforcement of the regulation (22:26), as some have suggested, and the FDA’s use of platform technology ideas for gene therapies not participating in the program (33:07). More On These Topics From The Pink Sheet As Biosecure Bill Mores Forward, Clock Ticking For Industry To Move Away From Chinese C...
May 2024 Datamonitor Healthcare Podcast: Neoadjuvant Therapy in Melanoma
May 17, 2024 00:05 - 16 minutes - 9.53 MBFlora gives an overview of the budding landscape of neoadjuvant therapy in melanoma and provides insight on the nuances of this market. Apple Podcasts - https://podcasts.apple.com/us/podcast/pharma-intelligence-podcasts/id923189836 Google Podcasts - https://podcasts.google.com/feed/aHR0cHM6Ly9mZWVkcy5zb3VuZGNsb3VkLmNvbS91c2Vycy9zb3VuZGNsb3VkOnVzZXJzOjEwNjU1NDkyOC9zb3VuZHMucnNz TuneIn - https://tunein.com/podcasts/Business--Economics-Podcasts/Pharma-Intelligence-Podcasts-p1140128/ Spo...
China Biotech Podcast - 15 May 2024 (Chinese- and English-Language)
May 15, 2024 07:25 - 35 minutes - 23 MBIn this bilingual Chinese- and English-language edition, China-based editors Brian Yang and Dexter Yan, along with guest speaker Derrick Gingery from the Pink Sheet in the US, discuss the planned US BIOSECURE Act and markup vote. Brian and Dexter also look at recent R&D updates from Chinese biopharma firms on their antibody-drug conjugate pipelines. https://scrip.citeline.com/SC150255/China-Biotech-Podcast-BIOSECURE-Markup-Biotech-Pipeline-Updates Other podcasts in the series: https://soundcl...
Scrip's Five Must-Know Things - 13 May 2024
May 13, 2024 05:46 - 14 minutes - 22.9 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 10 May 2024. In this episode: AstraZeneca’s Vaxzevria farewell; the next wave of cardiometabolics; Pfizer recruits prominent analyst: foundation pleas for China rare disease therapies; and Gossamer partners up for respiratory therapy. https://scrip.citeline.com/SC150240/Quick-Listen-Scrips-Five-MustKnow-Things Playlist: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things
Episode 15: Digital Trust
May 09, 2024 19:42 - 20 minutes - 18 MBIn this episode, Medtech Insight senior reporter Hannah Daniel speaks to Mark Brown, Global Managing Director of Digital Trust Consulting at the British Standards Institute about digital trust. In a world of cybersecurity breaches and ransomware attacks on hospitals, digital trust between companies and consumers is key, but current siloed operations can hinder that. We talk about the EU’s AI act, the speed of digital transformation, cybersecurity incentives, and how principle-based regulation...
Solving The Sustainable Pill Pack Puzzle, With PA Consulting’s Tony Perrotta
May 07, 2024 16:24 - 29 minutes - 67.5 MBIn this episode, HBW Insight chats with sustainable packaging expert Tony Perrotta about why it’s so difficult to replace plastic pill packs in medicines packaging. Perrotta works for PA Consulting, which set up the Blister Pack Collective alongside consumer healthcare partners Haleon, Bayer and Sanofi. They are working with PulPac, which has invented a dry molded fiber alternative to plastic, which the collective hopes will be ready to commercialize in the next 12-24 months. We discuss wheth...
Scrip's Five Must-Know Things - 7 May 2024
May 07, 2024 02:44 - 15 minutes - 18.9 MBAudio roundup of selected biopharma industry content from Scrip over the business week ended 3 May 2024. In this episode: Japan’s Ono buys US oncology firm; strong growth but supply issues for Lilly; Novo and Lilly make their money work; BMS cuts jobs, costs; and Big Pharma’s support for bioventures. https://scrip.citeline.com/SC150211/Quick-Listen-Scrips-Five-MustKnow-Things More podcasts in this series: https://soundcloud.com/citelinesounds/sets/scrips-five-must-know-things?si=17107bcf40ad4...
Drug Fix: US FDA Adcomm Reform, A Boost For Clinical Trial Modeling, AI For Drug Review
May 03, 2024 17:21 - 31 minutes - 19.9 MBPink Sheet reporter and editors discuss what an upcoming listening session means for the FDA’s advisory committee reform effort (:32), the agency’s efforts to help the clinical trial modeling and simulation industry (16:22), and the UK’s MHRA plan to use artificial intelligence to assist in drug application reviews (21:05). More On These Topics From The Pink Sheet US FDA Adcomm Reform: Does Listening Session Suggest No Major Near-Term Changes?: https://pink.citeline.com/PS150167/US-FDA-Ad...